Chen Hu

Chen Hu

Johns Hopkins University

H-index: 39

North America-United States

About Chen Hu

Chen Hu, With an exceptional h-index of 39 and a recent h-index of 36 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of Biostatistics, Clinical Trials, Oncology, Radiation Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

A New Pos-SIB-ility for Prostate and Pelvic Nodal Radiation Therapy in High-Risk Localized Prostate Cancer

Clinical features and outcomes of unresectable locally advanced non-small cell lung cancer with uncommon EGFR Mutations: A retrospective multi-center Chinese study

A Brief Report on the Patterns of Mediastinal Nodal Failure in Resectable Stage IB-IIIA NSCLC Treated With Neoadjuvant Immunotherapy Combinations, a Secondary Analysis of a …

Comprehensive genomic and transcriptomic analyses capture the effects of epigenetic therapy priming on immune checkpoint blockade response in non-small cell lung cancer

Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses

Association of overall survival benefit of radiotherapy with progression-free survival after chemotherapy for intermediate and high risk diffuse large B-cell lymphoma: a …

Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer

Iron Oxide Nanoparticles Inhibit Tumor Progression and Suppress Lung Metastases in Mouse Models of Breast Cancer

Chen Hu Information

University

Position

___

Citations(all)

8447

Citations(since 2020)

6535

Cited By

4137

hIndex(all)

39

hIndex(since 2020)

36

i10Index(all)

90

i10Index(since 2020)

82

Email

University Profile Page

Johns Hopkins University

Google Scholar

View Google Scholar Profile

Chen Hu Skills & Research Interests

Biostatistics

Clinical Trials

Oncology

Radiation Oncology

Top articles of Chen Hu

Title

Journal

Author(s)

Publication Date

A New Pos-SIB-ility for Prostate and Pelvic Nodal Radiation Therapy in High-Risk Localized Prostate Cancer

International Journal of Radiation Oncology, Biology, Physics

Scott C Morgan

Chen Hu

Robert T Dess

2024/1/1

Clinical features and outcomes of unresectable locally advanced non-small cell lung cancer with uncommon EGFR Mutations: A retrospective multi-center Chinese study

Kunpeng Xu

XiaoLi Zheng

Ming Chen

E Mingyan

Li Zhang

...

2024/3/25

A Brief Report on the Patterns of Mediastinal Nodal Failure in Resectable Stage IB-IIIA NSCLC Treated With Neoadjuvant Immunotherapy Combinations, a Secondary Analysis of a …

Clinical lung cancer

Serena Mao

Samuel Rosner

Patrick M Forde

Jamie E Chaft

David R Jones

...

2024/1/1

Comprehensive genomic and transcriptomic analyses capture the effects of epigenetic therapy priming on immune checkpoint blockade response in non-small cell lung cancer

Cancer Research

Blair V Landon

Kristen A Marrone

Michael J Topper

Akshaya Annapragada

Hua-Ling Tsai

...

2024/3/22

Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses

Nature medicine

Ronan J Kelly

Blair V Landon

Ali H Zaidi

Dipika Singh

Jenna V Canzoniero

...

2024/3/19

Association of overall survival benefit of radiotherapy with progression-free survival after chemotherapy for intermediate and high risk diffuse large B-cell lymphoma: a …

Jingnan Wang

Xin Liu

Yunpeng Wu

Qiuzi Zhong

Tao Wu

...

2024/4/23

Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer

Surgery Open Science

I-Chia Liu

Susan Gearhart

Suqi Ke

Chen Hu

Haniee Chung

...

2024/3/1

Iron Oxide Nanoparticles Inhibit Tumor Progression and Suppress Lung Metastases in Mouse Models of Breast Cancer

ACS nano

Preethi Korangath

Lu Jin

Chun-Ting Yang

Sean Healy

Xin Guo

...

2024/4/2

Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocol

Future Oncology

Jia-Ying Li

Shu-Nan Qi

Chen Hu

Xin Liu

Yong Yang

...

2024/2

Dynamic treatment regimes and biomarker-driven strategies: Bridging the two worlds

Ruizhe Chen

Chen Hu

2023/1/1

Patient‐derived tumor organoids predict responses to irinotecan‐based neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer

International Journal of Cancer

Tao Lv

Lijun Shen

Xiaoya Xu

Ye Yao

Peiyuan Mu

...

2023/2/1

Laparoscopic versus Open Pancreatoduodenectomy in Patients with Periampullary Tumors: A Systematic Review and Meta-analysis

Shahab Aldin Sattari

Ali Reza Sattari

Martin A Makary

Chen Hu

Jin He

2023/5/1

Dose-Volume Predictors for Radiation Esophagitis in Patients With Breast Cancer Undergoing Hypofractionated Regional Nodal Radiation Therapy

International Journal of Radiation Oncology* Biology* Physics

Dan-Qiong Wang

Na Zhang

Li-Hua Dong

Ya-Hua Zhong

Hong-Fen Wu

...

2023/9/1

The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC

Cancer Research Communications

Joanne B Weidhaas

Chen Hu

Ritsuko Komaki

Gregory A Masters

George R Blumenschein

...

2023/10/11

The impact of salvage radiotherapy initiation at PSA≤ 0.5 ng/ml on metastasis‐free survival in patients with relapsed prostate cancer following prostatectomy

The Prostate

Emerson E Lee

Tanmay Singh

Chen Hu

Misop Han

Curtiland Jr Deville

...

2023/2

Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection

Frontiers in immunology

Annukka AR Antar

Tong Yu

Zoe O Demko

Chen Hu

Jeffrey A Tornheim

...

2023/4/28

Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study

Annals of hematology

Jia-Ying Li

Xiao-Rong Hou

Si-Ye Chen

Xin Liu

Qiu-Zi Zhong

...

2023/9

Local Time-to-Event Endpoint Under-Reporting and Variability in Pancreatic Cancer Trials Involving Radiotherapy

International Journal of Radiation Oncology, Biology, Physics

TA Lin

S Mao

C Anker

JM Herman

JJ Meyer

...

2023/10/1

Induction of double-strand breaks with the non-steroidal androgen receptor ligand flutamide in patients on androgen suppression: a study protocol for a randomized, double-blind …

Trials

Emerson Lee

Jonathan Coulter

Alok Mishra

Fernanda Caramella-Pereira

Angelo Demarzo

...

2023/12/16

Risk stratification and prognostic value of multi-modal MRI-based radiomics for extranodal nasal-type NK/T-cell lymphoma

BMC cancer

Yu-Ting Zhao

Si-Ye Chen

Xin Liu

Yong Yang

Bo Chen

...

2023/1/25

See List of Professors in Chen Hu University(Johns Hopkins University)

Co-Authors

H-index: 118
Walter Curran

Walter Curran

Emory & Henry College

H-index: 93
Jeff Michalski

Jeff Michalski

Washington University in St. Louis

H-index: 87
Jeffrey Bradley

Jeffrey Bradley

Emory University

H-index: 76
Robert Timmerman

Robert Timmerman

University of Texas Southwestern Medical Center

academic-engine